Last updated on March 2017


Brief description of study


Detailed Study Description

A study to assess the efficacy and safety of PT010 relative to PT003 and PT009 on COPD exacerbations over a 52 week treatment period in subjects with moderate to very severe COPD. Phase III

Clinical Study Identifier: TX148177

Contact Investigators or Research Sites near you

Start Over

Lydia Baker

Northern Pines Health Center, PC
Buckley, MI USA
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.